findmyKOL
Clinical trialNCT05955924RecruitingPhase 3Interventional

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial

SponsorWomen's College HospitalEnrollment396Carcinoma, Basal CellCarcinoma, Squamous CellKeratinocyte CarcinomaNon-melanoma Skin Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Calgary

    Calgary, Alberta, Canada

    Ngam Lam
    Not, yet, recruiting
  • University of Alberta

    Edmonton, Alberta, Canada

    Jaggi RaoSita Gourishankar
    Recruiting
  • St. Paul'S Hospital

    Vancouver, British Columbia, Canada

    John GillSheila Au
    Recruiting
  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

    Sunil Kalia
    Recruiting
  • the Ottawa Hospital

    Ottawa, Ontario, Canada

    Jennifer Beecker
    Recruiting
  • Toronto General Hospital

    Toronto, Ontario, Canada

    An-Wen Chan
    Recruiting
  • Women'S College Hospital

    Toronto, Ontario, Canada

    An-Wen Chan
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Aug 2023
Primary completion
31 Aug 2027
Completion
31 Aug 2027
Last update posted
21 Feb 2025
Registered enrollment
396
Registry id
NCT05955924

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.